Zhejiang Ausun Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603229.SS

Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.01

Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share is USD 0.01 for the year ending December 31, 2023, a 135.57% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.04, a -1.43% change year over year.
Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.04, a -388.63% change year over year.
Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.01, a 28.20% change year over year.
Zhejiang Ausun Pharmaceutical Co., Ltd. Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.01, a 186.41% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shanghai Stock Exchange: 603229.SS

Zhejiang Ausun Pharmaceutical Co., Ltd.

CEO	Mr. Zhiguo Zheng
IPO Date	May 9, 2017
Location	China
Headquarters	No. 5 Donghai Fourth Lane
Employees	1,174
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Medical Instruments Personal Care Pet Food Plastics Tobacco

Description

Zhejiang Ausun Pharmaceutical Co., Ltd. develops, produces, and sells specialty drug substances and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it is involved in the processing, and research and development business. The company was founded in 2010 is based in Linhai, China.

Key trends

Past 5 years